General Information of Drug Off-Target (DOT) (ID: OTE5XENW)

DOT Name Neuronal acetylcholine receptor subunit beta-3 (CHRNB3)
Gene Name CHRNB3
Related Disease
Bipolar disorder ( )
Advanced cancer ( )
Alcohol dependence ( )
Attention deficit hyperactivity disorder ( )
Cocaine addiction ( )
Depression ( )
Epilepsy, idiopathic generalized ( )
Esophageal squamous cell carcinoma ( )
Lung cancer ( )
Lung carcinoma ( )
Non-small-cell lung cancer ( )
Parkinson disease ( )
UniProt ID
ACHB3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
8A5U
Pfam ID
PF02931 ; PF02932
Sequence
MLPDFMLVLIVLGIPSSATTGFNSIAENEDALLRHLFQGYQKWVRPVLHSNDTIKVYFGL
KISQLVDVDEKNQLMTTNVWLKQEWTDHKLRWNPDDYGGIHSIKVPSESLWLPDIVLFEN
ADGRFEGSLMTKVIVKSNGTVVWTPPASYKSSCTMDVTFFPFDRQNCSMKFGSWTYDGTM
VDLILINENVDRKDFFDNGEWEILNAKGMKGNRRDGVYSYPFITYSFVLRRLPLFYTLFL
IIPCLGLSFLTVLVFYLPSDEGEKLSLSTSVLVSLTVFLLVIEEIIPSSSKVIPLIGEYL
LFIMIFVTLSIIVTVFVINVHHRSSSTYHPMAPWVKRLFLQKLPKLLCMKDHVDRYSSPE
KEESQPVVKGKVLEKKKQKQLSDGEKVLVAFLEKAADSIRYISRHVKKEHFISQVVQDWK
FVAQVLDRIFLWLFLIVSVTGSVLIFTPALKMWLHSYH
Function After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
KEGG Pathway
Neuroactive ligand-receptor interaction (hsa04080 )
Reactome Pathway
Highly calcium permeable nicotinic acetylcholine receptors (R-HSA-629597 )
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors (R-HSA-629594 )

Molecular Interaction Atlas (MIA) of This DOT

12 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Bipolar disorder DISAM7J2 Definitive Biomarker [1]
Advanced cancer DISAT1Z9 Strong Genetic Variation [2]
Alcohol dependence DIS4ZSCO Strong Genetic Variation [3]
Attention deficit hyperactivity disorder DISL8MX9 Strong Biomarker [4]
Cocaine addiction DISHTRXG Strong Genetic Variation [5]
Depression DIS3XJ69 Strong Biomarker [6]
Epilepsy, idiopathic generalized DISODZC9 Strong Genetic Variation [7]
Esophageal squamous cell carcinoma DIS5N2GV Strong Genetic Variation [8]
Lung cancer DISCM4YA Strong Genetic Variation [9]
Lung carcinoma DISTR26C Strong Genetic Variation [9]
Non-small-cell lung cancer DIS5Y6R9 Strong Genetic Variation [9]
Parkinson disease DISQVHKL Limited Genetic Variation [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 12 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Folic acid DMEMBJC Approved Folic acid decreases the expression of Neuronal acetylcholine receptor subunit beta-3 (CHRNB3). [11]
DTI-015 DMXZRW0 Approved DTI-015 decreases the expression of Neuronal acetylcholine receptor subunit beta-3 (CHRNB3). [12]
Amphotericin B DMTAJQE Approved Amphotericin B increases the expression of Neuronal acetylcholine receptor subunit beta-3 (CHRNB3). [13]
Amiodarone DMUTEX3 Phase 2/3 Trial Amiodarone increases the expression of Neuronal acetylcholine receptor subunit beta-3 (CHRNB3). [14]
AM251 DMTAWHL Investigative AM251 increases the expression of Neuronal acetylcholine receptor subunit beta-3 (CHRNB3). [17]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Neuronal acetylcholine receptor subunit beta-3 (CHRNB3). [15]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the methylation of Neuronal acetylcholine receptor subunit beta-3 (CHRNB3). [16]
------------------------------------------------------------------------------------

References

1 Variants near CHRNB3-CHRNA6 are associated with DSM-5 cocaine use disorder: evidence for pleiotropy.Sci Rep. 2014 Mar 28;4:4497. doi: 10.1038/srep04497.
2 Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers.J Intern Med. 2016 Apr;279(4):388-98. doi: 10.1111/joim.12454. Epub 2015 Dec 22.
3 A functional U-statistic method for association analysis of sequencing data.Genet Epidemiol. 2017 Nov;41(7):636-643. doi: 10.1002/gepi.22063. Epub 2017 Aug 29.
4 Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood.Addict Behav. 2013 Nov;38(11):2683-9. doi: 10.1016/j.addbeh.2013.06.013. Epub 2013 Jul 1.
5 Rare missense variants in CHRNB3 and CHRNA3 are associated with risk of alcohol and cocaine dependence.Hum Mol Genet. 2014 Feb 1;23(3):810-9. doi: 10.1093/hmg/ddt463. Epub 2013 Sep 20.
6 Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer.Mol Psychiatry. 2009 Jun;14(6):563-89. doi: 10.1038/mp.2009.2. Epub 2009 Feb 10.
7 Evidence for linkage of adolescent-onset idiopathic generalized epilepsies to chromosome 8-and genetic heterogeneity.Am J Hum Genet. 1999 May;64(5):1411-9. doi: 10.1086/302371.
8 A genetic variant in CHRNB3-CHRNA6 increases risk of esophageal squamous cell carcinoma in Chinese populations.Carcinogenesis. 2015 May;36(5):538-42. doi: 10.1093/carcin/bgv019. Epub 2015 Mar 30.
9 Genetic variants of CHRNA5-A3 and CHRNB3-A6 predict survival of patients with advanced non-small cell lung cancer.Oncotarget. 2016 May 3;7(18):26436-43. doi: 10.18632/oncotarget.8510.
10 CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking.Neurobiol Aging. 2014 Sep;35(9):2179.e1-6. doi: 10.1016/j.neurobiolaging.2014.03.014. Epub 2014 Mar 20.
11 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
12 Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol. 2005 Jul;73(3):189-98.
13 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
14 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
15 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
16 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
17 Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism. FEBS Lett. 2006 Mar 20;580(7):1733-9.